Voyager Therapeutics

VYGR

NASDAQHealth Care

Income Statement

Total Revenue$80M

Gross Profit$80M

Operating Income$-83.29M

EBITDA$-56.18M

EBIT$-64.34M

Pre-tax Income$-116.52M

Net Income$-65M

Cash Equivalent$101.49M

Total Debt$10.93M

Book Value$326.59M

Book Value Per Share6.00

Return on Equity (ROE)-21.68%

Return on Assets (ROA)-16.54%

Return on Invested Capital (ROI)-21.68%

Net Profit Margin-81.25%

Current Ratio5.56

Quick Ratio5.50

Long-Term Debt / Equity0.00